摘要 |
<p>The present invention relates to methods for inhibiting proliferation and/or migration of lymphatic endothelial cells and for inhibiting lymphangiogenesis, comprising administering to a subject, or to lymphatic endothelial cells derived therefrom, an effective amount of a collagen type IV-derived NC1 domain polypeptide or a fragment, derivative or variant thereof, a polynucleotide encoding the same, or an agent capable of increasing the expression or production of the NC1 domain polypeptide. Also provided are methods for the treatment or prevention of diseases and conditions associated with aberrant lymphatic endothelial cell activity.</p> |
申请人 |
CRC FOR ASTHMA AND AIRWAYS LTD;BLACK, JUDITH LEE;BURGESS, JANETTE KAY;OLIVER, BRIAN GREGORY GEORGE;WECKMANN, MARKUS |
发明人 |
BLACK, JUDITH LEE;BURGESS, JANETTE KAY;OLIVER, BRIAN GREGORY GEORGE;WECKMANN, MARKUS |